---

Education:

• BS 1985 Pharmacy Medical University of South Carolina
• PhD 1989 Pharm.Sci. Medical University of South Carolina

Overview

Based on his background as both a pharmacist and pharmaceutical scientist, Dr. Elder holds a key leadership position for the Lenor Zeeh Pharmaceutical Experiment Station, which provides laboratory services to enable and support pharmaceutical and biopharmaceutical product development across campus and also for off-campus clients. In addition, the Station is influential in providing educational programs covering the process and science of drug development. Dr. Elder also serves as the School of Pharmacy liaison to the UW-Madison Office of Corporate Relations to assist with maintaining and developing relationships supporting the principles of the "Wisconsin Idea".

Prior to joining the UW School of Pharmacy in April 2006 as Associate Director of the Station and assuming the role of Director in July 2007, Ed served as pharmaceutics director and global technical leader, then global product development director for the BioAqueous* Solubilization Services offering from the Dowpharma* business unit of The Dow Chemical Company during a period of over 5 years. In this role he was responsible for managing the technical elements of a drug delivery business based on corporate particle engineering capabilities, leading a university collaboration involving nanoparticle formation technologies and applications, and providing pharmaceutics expertise for assessment of emerging business and technology development opportunities. From September 1989 through August 2000, Dr. Elder held various positions of increasing responsibility in scale-up and technology transfer, project management, new technology development, formulation and process development and optimization for dosage form design, and pharmaceutical development management at Glaxo and Glaxo Wellcome (now GlaxoSmithKline). In this capacity, his responsibilities included leading a formulation and process development group, serving as the chemistry, manufacturing and controls (CMC) team leader for several new product development programs and also participating as a key member of international development strategy and manufacturing strategy teams affiliated with various new chemical entities. (*Service Mark of The Dow Chemical Company)

Work-Related Interests/Research:

Dr. Elder has made several scientific presentations at national and international pharmaceutical industry meetings. He is a member of the Editorial Advisory Board for Drug Development and Industrial Pharmacy and a reviewer for several other journals in the pharmaceutical sciences. Ed was previously active in the AAPS Visiting Scientist Program for Schools of Pharmacy, having visited fourteen (14) colleges and universities from 1994-2006 (including UW-Madison in 2005). Furthermore, he has served as a guest lecturer on various occasions at four additional universities. Dr. Elder is a member of the American Association of Pharmaceutical Scientists (AAPS), Sigma Xi (The Scientific Research Society), the European Federation for Pharmaceutical Sciences (EUFEPS) and the UW-Madison Speakers Bureau.

Highlighted Publications:

• ME Matteucci, BK Brettmann, TL Rogers, EJ Elder, RO Williams III, and KP Johnston, Design of Potent Amorphous Drug Nanoparticles for Rapid Generation of Highly Supersaturated Media, Molecular Pharmaceutics, 4(5): 782-793 (2007).
• EJ Elder, JC Evans, BD Scherzer, JE Hitt, GB Kupperblatt, SA Saghir and DA Markham, Preparation, Characterization, and Scale-up of Ketoconazole with Enhanced Dissolution and Bioavailability, Drug Development and Industrial Pharmacy, 33:7,755 - 765 (2007).
• EJ Elder, JE Hitt, TL Rogers, CJ Tucker, SA Saghir, S Svenson and JC Evans, Particle Engineering of Poorly Water Soluble Drugs by Controlled Precipitation, Chapter 19 in Polymeric Drug Delivery Volume II - Polymeric Matrices and Drug Particle Engineering, Svenson, S., (Ed.), ACS Symposium Series, Vol. 924, American Chemical Society, Washington, DC (2006).
• JC Evans, BD Scherzer, CD Tocco, GB Kupperblatt, JN Becker, DL Wilson, SA Saghir and EJ Elder, Preparation of Nanostructured Particles of Poorly Water Soluble Drugs via a Novel Ultra-Rapid Freezing Technology, Chapter 21 in Polymeric Drug Delivery Volume II - Polymeric Matrices and Drug Particle Engineering, Svenson, S., (Ed.), ACS Symposium Series, Vol. 924, American Chemical Society, Washington, DC (2006).
• TL Rogers, IB Gillespie, JE Hitt, KL Fransen, CA Crowl, CJ Tucker, GB Kupperblatt, JN Becker, DL Wilson, C Todd, CF Broomhall, JC Evans and EJ Elder, Development and Characterization of a Scalable Controlled Precipitation Process to Enhance the Dissolution of Poorly Water-Soluble Drugs, Pharmaceutical Research, 21(11): 2048-2057 (2004).
• RD Connors and EJ Elder, Using a Portfolio of Particle Growth Technologies to Enable Delivery of Drugs with Poor Water Solubility, Drug Delivery Technology, 4(8): 78-83 (2004) .
• EJ Elder (contributor), Dosage Forms (Clinical Supplies and Commercial Product): APIs, Excipients and Raw Materials, Chapter 5.3 in Technology Transfer (ISPE Good Practice Guide), ISPE, Tampa, FL (2003).